
INOVIO PHARMACEUTICALS, INC. INO
INOVIO PHARMACEUTICALS, INC. statistics & valuation
P / B3.8×
Net margin-130000.0%
FCF margin-136074.5%
Return on capital-283.3%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Net margin (%)Gross margin (%)Operating margin (%)Return on equity (%)Shares outstandingNet debt ($)Share buybacks ($)Return on assets (%)Free cash flow margin (%)Debt / equity (×)EPS ($) Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Operating margin | -132871.3% | -51616.9% | -17300.3% | -2607.4% | -16972.3% | -1674.2% | -2702.1% | -308.7% | -198.1% | -215.5% |
| Net margin | -130000.0% | -49254.3% | -16239.9% | -2726.7% | -17109.9% | -2245.4% | -2902.8% | -318.1% | -208.9% | -208.5% |
| FCF margin | -136074.5% | -48019.1% | -14986.2% | -2116.3% | -12223.6% | -2422.0% | -2403.7% | -248.1% | -174.1% | -184.6% |
| Return on assets | -114.3% | -94.7% | -79.0% | -80.3% | -61.2% | -30.8% | -82.9% | -74.0% | -47.1% | -42.5% |
| Return on equity | -352.5% | -156.6% | -115.1% | -125.8% | -76.0% | -36.1% | -2208.4% | -111.4% | -61.9% | -59.8% |
| Debt / equity | — | — | — | — | — | — | — | 0.00× | — | — |
| Current ratio | 1.40 | 2.77 | 3.60 | 3.25 | 6.82 | 11.30 | 2.94 | 2.49 | 3.91 | 2.84 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.